tiprankstipranks
Damora Therapeutics (DMRA)
NASDAQ:DMRA
US Market
DMRA
Damora Therapeutics
RESEARCH TOOLSreports
Want to see DMRA full AI Analyst Report?

Damora Therapeutics (DMRA) Income Statement

325 Followers

Damora Therapeutics Income Statement

Last quarter (Q4 2025), Damora Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Damora Therapeutics's net income was $-200.74M. See Damora Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -181.00K$ -830.00K$ -490.00K$ -441.00K
Operating Expenses
$ 210.87M$ 16.72M$ 35.63M$ 60.72M$ 51.79M
Depreciation and Amortization
$ 34.00K$ 181.00K$ 830.00K$ 490.00K$ 441.00K
EBITDA
$ -210.84M$ -16.72M$ -35.63M$ -60.72M$ -51.79M
Operating Income
$ -210.87M$ -16.90M$ -36.46M$ -61.21M$ -52.23M
Other Income/Expenses
$ 1.08M$ -4.50M$ -1.89M$ -417.00K$ 475.00K
Pretax Income
$ -209.79M$ -21.40M$ -38.35M$ -61.62M$ -51.75M
Net Income
$ -209.84M$ -21.44M$ -38.35M$ -61.62M$ -51.75M
Per Share Metrics
Basic EPS
$ -158.13$ -18.53$ -36.08$ -60.63$ -51.22
Diluted EPS
$ -158.13$ -18.53$ -36.08$ -60.63$ -51.22
Weighted Average Shares Outstanding
 1.33M 1.16M 1.06M 1.02M 1.01M
Weighted Average Shares Outstanding (Diluted)
 1.33M 1.16M 1.06M 1.02M 1.01M
Currency in USD

Damora Therapeutics Earnings and Revenue History